DOCSLIB.ORG

Short Term Award Tuberculosis Prevention and Elimination (Cohorts I – III)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Short Term Award Tuberculosis Prevention and Elimination (Cohorts I – III) Australia Awards in Indonesia - Short Term Award Tuberculosis Prevention and Elimination (cohorts I – III) AAI Group 2 at the Alfred Medical Research and Education Precinct, Melbourne, with Course Facilitators Dr Philipp du Cros, Prof Steve Graham, Dr Suman Majumdar, Dr Khai Huang, Dr Trisasi Lestari and Stephanie Main. Photo: The Burnet Institute. Highlights Overview Three pre-course workshops in Seventy-six Indonesian health profes- The course leaders were Associate Makassar (Courses 1&2) and Surabaya sionals including doctors, nurses, Professor Anna Ralph, infectious (Course 3) community health workers, ministry diseases physician at the Menzies and local government’s health policy School of Health Research, Dr Steven Three two-week courses in Australia at makers participated in three Australia Graham, senior TB advisor and Dr the Menzies School of Health Research Awards Tuberculosis Prevention and Philipp du Cros, infectious TB special- and the Burnet Institute Elimination short term awards in 2018. ist at the Burnet Institute. Visits to The Centenary Institute, the The course equipped stakeholders Victorian Infectious Disease Reference and policy makers in Indonesia to Laboratory (Doherty Institute) and the control and eliminate TB infection, with Royal Darwin Hospital a long-term goal to further decrease the national TB prevalence and meet Award Project development and national targets by 2019. presentations Short Term Award (STA) Program Networking events attended by global health experts, Australia Awards in Beginning with a three-day pre-course Indonesia (AAI) Short Term Award workshop in Makassar (Courses 1 and malaria groups and AAI alumni 2) and Surabaya (Course 3), STA cohorts got off to a strong start, Three post-course workshops in AAI Group 1 completing the pre-course in dividing into groups and developing Yogyakarta (Courses 1&2) and Makassar Makassar show the “TOSS TB” hand sign. concept notes for their Award Projects (Course 3) based on situational, problem and Using key principles for tuberculosis solution analyses of current TB Expert panel discussions and keynotes (TB) elimination, the course was programs in Indonesia. This was delivered by global TB experts and accompanied by keynotes from Conference-style poster sessions health professionals from the Menzies Indonesian Ministry of Health staff and summarising Award Projects School of Health Research (Darwin), presentations on TB epidemiology the Burnet Institute (Melbourne) and and key international and national TB Ongoing communication and University Gadjah Mada (Yogyakarta). policies from global experts. networking on digital platforms Following the pre-course workshops, For the third post-course program, the STA cohorts travelled to Australia for newly-appointed head of the National intensive two-week courses conducted TB Program, Dr Imran Pambudi, joined in Melbourne and Darwin (STA Group the panel alongside Bey Sonata from 1) or Melbourne and Sydney (STA KNCV Tuberculosis Foundation and Groups 2&3), from 12 th – 23 rd of March course facilitators for an engaging (STA Group 1), 30 th April – 11th May conversation on case finding in Indone- (STA Group 2) and 10 th – 21st Septem- sia. This panel emphasised the huge ber (STA Group 3). engagement the courses have had in Indonesia and Australia, and the collab- The course program consisted of a orations they have fostered. comprehensive overview of TB in AAI Group 1 participants at the Burnet Institute, Indonesia and the world, focusing on Melbourne. AAI’s commitment to fund the three leading issues such as drug-resistant best award projects across three TB treatment, TB/HIV management, cohorts was welcomed by both partici- paediatric TB diagnosis, TB prevention Post Award pants and the Indonesian Ministry of and ‘missing’ TB cases/case notifica- Health. One of the three best posters tions. The course embedded leading Course 1 and 2 participants and went on to win the poster competition global health frameworks for TB facilitators met again in Yogyakarta, held by the Ministry of Health at the TB elimination such as the Search, Treat after a three-month project implemen- International Conference in Makassar. and Prevent strategy and used interac- tation period, at the post-course work- tive group work, analysis of cases and shop. Group 3 met in Makassar for the The three AAI STA Tuberculosis scenarios from the region, ‘Meet the third workshop. The workshops Prevention and Elimination courses Expert’ panel discussions, site visits, focused on reflecting on what the were a great success, creating endur- presentations and peer learning to participants had learned during the ing networks and relationships cement key course objectives. program, presenting the Award amongst Australian and Indonesian Projects, which included a poster health professionals and their institu- conference on the first day. This tions, strengthening the mission to end allowed STA Groups 1&2 to meet and the suffering from TB in Indonesia, the see what their colleagues had region and the world. designed and developed, which includ- ed innovative health promotion tools, case finding initiatives and a TB guide- lines smartphone application. Groups discussed the challenges they had faced and their next steps and learnt about tools for effective health commu- nication, writing policy briefs and academic papers. Participants and course facilitators at a Participants appreciated a panel Parliamentary Reception Hosted by Northern discussion focusing on TB policy, Territory Minister of Health Natasha Fyles. research and elimination tools present- AAI Group 2 at the Burnet Institute’s research ed by Dr Yodi Mahendradhata, Dr laboratories. Clinical, community health, health Pandu Riono, A/Prof Anna Ralph, Dr systems, research and public health Philipp du Cros, Dr Rina Triasih and Dr Linkages experts delivered the program. They Trisasi Lestari. Likewise, a keynote from A collaboration has been forged covered a spectrum of key topics to Dr Aamir Khan, Executive Director of between Dr Rina Triasih (co-facilitator equip course participants with the Interactive Research and Development from University Gadjah Mada), Dr knowledge and practical skills to (IRD) (which is implementing the Donnie Ahmad (guest speaker from design, implement, monitor and Search, Treat & Prevent approach in University Gadjah Mada at the evaluate innovative TB projects in Karachi, Pakistan, arguably one of the post-course program in Yogyakarta), Indonesia. Further, throughout the most comprehensive TB elimination the Centre for Tropical Medicine in course, participants gained extensive programs in the world) was an inspiring Yogyakarta, the Burnet Institute, project development and design skills, call to action to conclude the course. Menzies School of Health Research, devoting 1.5 hours a day to Yogyakarta stakeholders (District comprehensively developing their Health Offices and NGOs) and Dr Amir Award Projects. Concluding the course, Khan from IRD to implement a Zero TB participants presented their Award Cities program in Yogyakarta. This has Projects to the group. been endorsed by the Yogyakarta Finally, site visits and networking mayor, and is a promising TB collabo- evenings in Australia at Menzies School ration between Australian, Indonesian of Health Research, the Burnet Institute, and regional organisations that came the Royal Darwin Hospital’s Infectious together during the course. Disease Department, Northern Territory Parliament House, the Victorian Since the combined post-course, Infectious Disease Reference Mimika Provincial Health Office in AAI Group 2 at the Alfred Medical Research and Papua, where A/Prof Anna Ralph is Laboratory and the Centenary Institute Education Precinct, Melbourne, with Course delivery team principal investigator gave the participants personal insights Facilitators Dr Philipp du Cros, Prof Steve and Dr Trisasi Lestari is the TB into the everyday workings of a TB Graham, Dr Suman Majumdar, Dr Khai Huang, Dr reference laboratory, infection control in Trisasi Lestari and Stephanie Main. Photo: The an Australian hospital and world-class Burnet Institute. research institutions. Participants’ testimonials “Never once in my life have I experienced “Everything was beyond expectation: to an institution concerned so much about obtain learning materials from Australian TB my needs as a wheelchair user. I was experts who've had many international very thankful that you provided an electric publications was one thing that wouldn't wheelchair and accessible apartment for have happened to me if I didn't get the STA me. It had a great impact for me as I felt from AAI. I felt very lucky to have been really respected by all of you.” trained in such excellent facilities. Visiting Melbourne was a very memorable experience - what a beautiful and friendly city. Thank you, AAI and Burnet.” AAI Group 2 participants discussing the Tubercu- losis BCG vaccine and new vaccine innovations with Prof Warwick Britton at The Centenary Institute, University of Sydney. Award Project Poster Conference at the contact screening and management post-course workshop in Yogyakarta. project manager, have been collaborat- ing with a STA project team to imple- Contacts ment their “puzzle” health promotion tool in Timika. In addition, a number of GASAK Group presenting their Award Project A/Prof Anna Ralph, AAI participants from other Papuan poster to fellow participants and discussing the challenges and next steps. Course Lead, Menzies School of districts have visited Timika
Load more

Recommended publications
  • The Bursa of Fabricius Award 12 ASI Councillors' News 13 Caption Competition 16 ASI Inc
    NEWSLETTER Australasian Society for Immunology Incorporated PP 341403100035 ISSN 1442-8725 March 2004 How to win a Nobel Prize in Physiology or Medicine Gordon Ada, John Curtin School of Medical Research When one thinks of winners of Nobel Prizes November to celebrate his contributions and at the Institute for 19 years when Frank came in these disciplines, there is a tendency to achievements. Peter and Rolf were present as to visit me in 1967. He told me he had visualize mature scientists who after many well as many of his past students (from 1972 relinquished the Headship of the Department years of laboratory work have accumulated to 2003) and others who worked in the of Microbiology to become the Director of lots of evidence to prove a particular concept Department, mainly in the 1970s. The the John Curtin School. He asked whether I or theory. This certainly happens, but there contributions, especially by past students, would let my name go forward as a candidate are many other situations. For example, one were remarkable for the variety of topics to succeed him as Head of the Microbiology recipient has provided the concept which a presented. Department? I decided yes, because under co-recipient has independently proven it to Frank Fenner, the Microbiology Department be correct. (e.g. Immunological tolerance, In the late 1960s I was happily working at the had reached international status and if I went Burnet and Medawar, 1960). In contrast, the Walter and Eliza Hall Institute (WEHI) with there, I could bring virology and immunology 1996 Prize resulted from a rather unusual Gus Nossal as a close colleague.
    [Show full text]
  • 2006 Annual Report
    Centenary Institute report annual 06 OUR LOGO The letter “C” set in sandstone in the logo, has dual symbolism. It reflects our commitment to cancer research and, as the Roman Numeral for 100, it represents our association with the Centenaries of the University of Sydney Medical School and Royal Prince Alfred Hospital. Our mission To improve the quality of life for all Australians through excellence in medical research Centenary Institute Annual Report 2006 www.centenary.org.au 3 Contents Page 2006 Highlights 4 Director’s Report 6 From The Chairman 7 Report from Incoming Executive Director 8 Board of Governors 9 Our History 11 Organisational Chart 12-13 Research Groups 14 Cell Biology 14 Gene and Stem Cell Therapy 18 Liver Immunobiology 20 Molecular Cardiology 25 Mycobacterial Research 26 T Cell Biology 29 Core Facilities 31 Postgraduate Training Programme 33 2006 Seminar Series 35 2006 Publications 38 2006 Presentations 41 Centenary Committees 47 2006 Staff List 48 2007 – The Year Ahead 51 Fundraising 53 Centenary Institute Annual Report 2006 4 2006 Highlights • Centenary Institute’s Agnes Ginges Centre for Molecular capacity of infected macrophages to die through Cardiology, headed by Associate Professor Chris apoptosis and kill mycobacteria. In separate studies Semsarian, have identified several ‘killer’ genes the group showed that the recently recognised believed to be responsible for sudden cardiac death cytokine IL-23 is effective for increasing the immune (SCD) following tests on more than 400 Australian response and protective effect of DNA vaccines against families with a history of heart disease. The group is TB and that this cytokine can compensate for IL-12 amongst the first to report the association between deficiency in controlling TB in mice.
    [Show full text]
  • Influenza Susceptibility Linked to Variable Responses to Interferons in the Lung
    MEDIA RELEASE Wed 11th December 2019 Influenza susceptibility linked to variable responses to interferons in the lung Researchers at the Centenary Institute and the University of Sydney have discovered a key reason as to why the influenza virus is so effective at establishing infection and causing damage in the lungs. They found that a group of lung-cells, following influenza infection, responded only poorly to interferons (the signalling proteins that help defend the body against viral attack). The research could pave the way for the development of new and improved anti-influenza drugs and vaccines, to both improve health and to save lives. “Interferons are critically essential to our defence against pathogens including the influenza virus,” said Associate Professor Carl Feng, senior study author from the Centenary Institute and the University of Sydney. “The proteins are so named because they ‘interfere’ with the ability of viruses to multiply in the body.” “It’s been known for a long time that during influenza, lung cells and immune cells in the lungs secrete interferons causing virus-infected cells to initiate anti-viral defences,” said Associate Professor Feng. “However, how interferons actually undertake this protective activity is still not understood because the signalling proteins can act on hundreds of different types of cells in our body,” he said. In their study, Associate Professor Feng and colleagues have generated a new tool to identify which cells respond to interferons in influenza infected mice. The goal was to work out whether the outcome of infection and interferon signalling differed between different cell types. What the researchers have demonstrated in the study is that not every cell type reacts equally to the interferons, even when they are in close proximity to each other.
    [Show full text]
  • Survey of Commercial Outcomes from Public Research (Scopr) 2019 Report
    techtransfer.org.au SURVEY OF COMMERCIAL OUTCOMES FROM PUBLIC RESEARCH (SCOPR) 2019 REPORT Survey and report delivered by FOREWORD There is an ever-present imperative to capture the commercial value of our research endeavour for our future wellbeing. To do so strategically, decision makers from laboratory, institutional and government levels need insights into how the research sector is currently engaging with industry to transfer knowledge and innovation, and thereby deliver benefits to our society from the fruits of our research. For many years in Australia there has been a focus on improving innovation metrics, thus I am delighted to acknowledge the initiative of gemaker and Knowledge Commercialisation Australasia (KCA) in producing the inaugural Survey of Commercial Outcomes from Public Research (SCOPR). The SCOPR takes its lead from the National Survey of Research Commercialisation (NSRC) produced since 2000 by the Department of Industry, Science, Energy and Resources. To avoid duplication, the Department has decided to cease the NSRC and will work with KCA to share knowledge, and access data collected by SCOPR. As we face the COVID-19 pandemic, effective knowledge transfer is more important than ever, so I hope that this report will spur our research institutions to even greater achievements. Realising effective knowledge transfer will depend on having skilled commercialisation professionals who can help researchers turn great ideas into beneficial products and services. I applaud KCA’s support for technology transfer professionals
    [Show full text]
  • Discovery First Step to New Therapies Many of Our Scientists Have Achieved Strong Results in Their Research Throughout the Year
    Newsletter of the Centenary Institute OCTOBER 08 LuminesCent Dr Mika Jormakka hopes to improve treatments for diseases like cancer by mapping complex Welcome to the October 2008 issue of structures called membrane proteins. LuminesCent, wrapping up a very busy and exciting year for the Centenary Institute. Discovery first step to new therapies Many of our scientists have achieved strong results in their research throughout the year. In this edition we In an Australian first, scientists at the Centenary Institute have mapped the feature two, Dr Mika Jormakka (page 1) and Associate anatomy of a membrane protein. This exciting discovery has the potential to turn Professor Chris Semsarian (page 5), who had their work the way we discover new drugs on its head and reduce the development time published in highly respected international journals. for new treatments. One of our promising young researchers, Dr Jeff Holst, of “These membrane proteins are the target for 70% of all therapeutic drugs so the Gene and Stem Cell Therapy program, talks about an increased understanding of them is vital for future drug discoveries,” said his investigations into prostate cancer, the most common Centenary Institute Executive Director, Professor Mathew Vadas. cancer diagnosed in Australian men, on page 4. The Centenary Institute recently unveiled a confocal Publishing in the prestigious international journal, Nature Structural & Molecular microscope that produces 3D images and video for Biology, Dr Mika Jormakka, head of Centenary’s Structural Biology laboratory, says improved investigation of diseases such as cancer and understanding membrane protein structures will help develop better treatments heart disease. Read about it on page 2.
    [Show full text]
  • 2005 Annual Report
    Centenary Institute report annual 05 OUR LOGO The letter “C” set in sandstone in the logo, has dual symbolism. It reflects our commitment to cancer research and, as the Roman Numeral for 100, it represents our association with the Centenaries of the University of Sydney Medical School and Royal Prince Alfred Hospital. Our mission To improve the quality of life for all Australians through excellence in medical research Centenary Institute Annual Report 2005 www.centenary.org.au 3 Contents Page 2005 Highlights 4 Director's Report 7 Farewell to Professor Antony Basten 8 Interim Director's Report 10 Board Governors 11 Our History 13 Organisational Chart 14 Research Groups 16 Cell Biology 16 Antibody Gene Recombination & Mutation 16 Cancer Drug Resistance 17 Lymphocyte Differentiation 18 Molecular & Cellular Responses 19 Type 1 Diabetes 20 Cellular Immunity 21 Gene and Stem Cell Therapy 22 Liver Immunobiology 24 Liver Immunology 24 Molecular Hepatology 25 Transplantation 26 Molecular Cardiology 28 Mycobacterial Research 29 Host Responses to Infection 30 Vaccine Development & Mycobacterial Pathogenesis 31 T Cell Biology 32 Core Facilities 34 Postgraduate Training Programme 36 2005 Seminar Series 38 2005 Publications 40 2005 Presentations 43 Centenary Committees 51 2005 Staff List 52 Research Groups 52 2006 - The Year Ahead…. 55 Fundraising 56 Centenary Institute Annual Report 2005 4 2005 Highlights Major equipment upgrade • Associate Professor Chris Semsarian, head of Centenary's Agnes Ginges Centre for Molecular In June 2005 Centenary took delivery of three new flow Cardiology, was the runner-up in the 2005 Royal Prince cytometers from BD Biosciences valued at $1.7 million, Alfred Research Medal presentations.
    [Show full text]
  • Biomarker Signature Found for TB Infection
    MEDIA RELEASE 8 May 2020 Biomarker signature found for TB infection A group of leading Australian researchers have uncovered a unique blood-based biomarker signature in individuals infected by tuberculosis (TB). The presence of the biomarker signature, found through a simple blood test, allows individuals with infectious TB–including those with non-symptomatic early-stage disease– to be easily identified and treated. The finding, reported in the Journal of Infection, could be key in supporting health efforts to control and eventually eliminate the TB epidemic which is responsible for approximately 1.5 million deaths each year globally. “A major issue in controlling the spread of tuberculosis is the difficulty of detecting the disease quickly and effectively, particularly in developing countries and in remote areas where technology and testing facilities may be limited,” says lead author of the study, Dr Jennifer Ho from the Centenary Institute and the Woolcock Institute of Medical Research “Sputum smear microscopy is the test used to diagnose TB in the majority of endemic settings but it is unable to pick-up TB in its early stages which prevents timely diagnosis and treatment.” “Also problematical are individuals with latent TB who possess no physical sickness or symptoms,” she says. “Unaware they are infected, these individuals can become TB spreaders if their disease progresses at some point to an active state.” Dr Ho notes that it is estimated that over 3.3 million cases of active TB are undetected annually, contributing to the uncontrolled spread of TB. “Our biomarker discovery could be used as the basis for a highly effective and simple diagnostic blood test to help detect these prevalent cases of TB in the community,” she says.
    [Show full text]
  • Snow Fellowships 2020 Application Round - Eligible Host Organisations
    Snow Fellowships 2020 Application Round - Eligible Host Organisations Entity name Asbestos Diseases Research Institute Australian Catholic University Limited Australian Centre for Heart Health Australian Institute of Aboriginal and Torres Strait Islander Studies Australian National University Baker Heart and Diabetes Institute Bionics Institute Black Dog Institute Bond University Limited Brien Holden Vision Institute Burnet Institute Centenary Institute of Cancer Medicine and Cell Biology Central Australian Aboriginal Congress Aboriginal Corporation Central Queensland University Centre for Eye Research Australia Limited Charles Darwin University Charles Sturt University Children's Cancer Institute Children's Medical Research Institute Chris O'Brien Lighthouse Curtin University Deakin University Doherty Institute Ear Science Institute Australia Incorporated Edith Cowan University Federation University Australia Flinders University Florey Institute of Neuroscience and Mental Health Garvan Institute of Medical Research George Institute for Global Health Griffith University Hanson Institute Harry Perkins Institute of Medical Research Heart Research Institute Hudson Institute of Medical Research Hunter Medical Research Institute Ingham Institute Institute for Breathing and Sleep James Cook University Kolling Institute of Medical Research La Trobe University Lions Eye Institute Macquarie University Mater Research Limited Melanoma Institute Australia Menzies School of Health Research Monash University Murdoch Children’s Research Institute Murdoch
    [Show full text]
  • 2012 Annual Report (3.9MB PDF File)
    Annual Report RESEARCH2012 HIGHLIGHT OF THE YEAR Our group has made significant advances in understanding disease progression related to iron metabolism, but also on a more translational level, advances in characterising the effects of drug therapies in cancer. We have provided new insight into disease causing iron acquisition through a particular iron transporter, and have characterised specific lead drug candidates targeting the LAT transporters in prostate cancer cells. OUR HISTORY The Centenary Institute opened in 1989, under the stewardship of its founding Director Professor Anthony Basten, to commemorate the centenaries of the University of Sydney Medical School and the Royal Prince Alfred Hospital. Formal working relationships with the University and Hospital have provided unique opportunities for students to become involved both in research and the translation of basic discoveries into clinical practice, an area in which the Institute has become a leader. The Centenary Institute is a world class medical research facility focusing on cancer, cardiovascular and infectious diseases. It is located between Royal Prince Alfred Hospital and the University of Sydney, and forms a critical point of contact and intellectual engagement between the Hospital and the University. 2012 Scientific Image Prize Winner – ‘The Spark of Life’. Dr David Hancock, T cell Biology. Understanding the complexity of the immune system using advanced bioinformatics. A network map displaying all interactions in an immune cell after activation. Centenary Institute
    [Show full text]
  • 2014 Annual Report
    2014 ANNUAL REPORT Understanding CONTENTS DISEASE THE YEAR IN REVIEW RESEARCH LABS & GROUPS Chairman & Executive Ageing Director Report Agnes Ginges Disease of the Aorta 1 4 Bioinformatics ABOUT CENTENARY Cardiovascular Signalling Board of Governors Cellular Mechanobiology Scientific Advisory Board DNA Repair 2 Scientific Support Host Responses to TB Centenary Foundation Human Viral & Cancer Immunology Fundraising Committee Liver Cell Biology YCF Melanoma Cell Biology Community Fundraising Molecular Hepatology Origins of Cancer RESEARCH PROGRAMS Gene & Stem Cell Therapy HIGHLIGHTS & AWARDS Immune Imaging Financial Highlights 3 Liver Immunology 5 2014 Award Recipients Liver Injury and Cancer CI Lawrence Creative Prize Molecular Cardiology Structural Biology SCIENTIFIC EXCELLENCE T Cell Biology 2014 Publications Tuberculosis 6 Invited Presentations Vascular Biology Collaborations Grant Recipients Organisational Chart Finding a CURE 5 granting bodies last year. wide, we are now known CEO of Cochlear, In addition Serena Stewart, for initiating the Centenary who will join our Board of 1 2014 the new head of our Institute Lawrence Creative Governors in early 2015. Marketing and Fundraising Prize (CILCP), which IN REVIEW team, has systematically recognises the most Many thanks to Professor EXECUTIVE DIRECTOR MATHEW VADAS AO FAHMS | CHAIRMAN THE HON MICHAEL EGAN AO put into place a strategy talented young scientists Barbara Fazekas for her and developed a team to in Australia and promotes assistance and guidance significantly improve our their careers. during her term as There has never atmosphere, we look protecting our children fundraising capabilities Assistant Director. We also been a more back on 2014 as a and next generations from and engagement with More locally, we are thank Professor Wolfgang exciting time in hugely successful year some of the most chronic our donors (individual enthusiastic members of Weninger for his ongoing biomedical science.
    [Show full text]
  • 2020 Annual Report PHOTOGRAPH CREDITS: Pp
    Response and Recovery 2020 Annual Report PHOTOGRAPH CREDITS: pp. 13/18/back cover, Brett Summerell; p. 19, CDC/Alissa Eckert, MSMI; Dan Higgins, MAMS. Contents Chairman’s 2019/2020 Bioplatforms report Highlights Australia 2 4 5 Bioplatforms Bioplatforms Feature network activities stories 6 7 8 Network National Collaboration LEADERSHIP access Initiatives and partnerships Bioplatforms Australia is committed to maintaining a high standard of governance and leadership. Strategic direction and operational oversight is provided by an independent Board of Directors and supported by an Executive Management Committee who advise on platform technologies and organisational initiatives. Board Members and Responsibilities Executive Management Committee 10 13 16 Bioplatforms Australia’s Directors offer a wealth of experience The Executive Management Committee manages and advises across scientific, business and government domains. on platform issues and operations. It is also responsible for Industry Capabilities BioCommons Each Director has responsibility for particular aspects of implementing strategic initiatives, including Commonwealth engagement network organisational strategy in addition to their fiduciary duties. funding agreements established with network partners. Dr Leslie Trudzik – Chairman Committee members are: Les is a founding Board Member of Bioplatforms Australia and Chair became Chairman in 2013. He is responsible for developing the Andrew Gilbert, Chief Executive, Bioplatforms Australia organisation’s performance and impact framework.
    [Show full text]
  • 2003 Annual Report
    Centenary Institute The Key of Life Annual Report 2002 – 2003 Centenary Institute of Cancer Medicine and Cell Biology Contents Centenary Institute 2 From the Director 3 Centenary Institute Annual Research 5 Review The Director’s Laboratory 6 Molecular Cardiology Laboratory 11 Immune Regulation Laboratory 14 Cancer Drug Resistence Laboratory 16 Liver Immunobiology Laboratory 19 Mycobacterial Research Laboratory 24 T Cell Biology Laboratory 27 Gene Therapy Laboratory 32 Research Funding 2002/ 03 35 Publications 2002 /03 37 Board of Governors 43 Institute Staff 45 - 1 - Centenary Institute The Centenary Institute of Cancer Medicine and Cell Biology is a centre of excellence in medical research. The Institute specialises in the diagnosis, prevention and treatment of diseases ranging from cancer, Type 1 Diabetes and allergy, to genetic heart disease and tuberculosis. Our strategy is to undertake ‘cutting edge’ research into the biology of normal and diseased cells, with the goal of improving our understanding of what causes disease and to translate these discoveries into clinical practice through development of new vaccines, better diagnostic tests and innovative forms of treatment. The Centenary Institute was conceived in 1982 to commemorate the Centenaries of the University of Sydney Medical School and the Royal Prince Alfred Hospital. Formal affiliations with both organisations promote the opportunities for students to become involved in research as well as the extrapolation of research theories to practice. The Institute is located in the grounds of Royal Prince Alfred Hospital adjacent to the Medical School and University Campus, in a purpose built facility capable of accommodating a research team of up to 150 career investigators, trainees and support staff.
    [Show full text]